Information Program on Clinical Trials for Serious and Life-Threatening Diseases: Maintaining a Databank

ICR 200402-0910-005

OMB: 0910-0459

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
ICR Details
0910-0459 200402-0910-005
Historical Active 200011-0910-003
HHS/FDA
Information Program on Clinical Trials for Serious and Life-Threatening Diseases: Maintaining a Databank
Extension without change of a currently approved collection   No
Regular
Approved without change 05/18/2004
Retrieve Notice of Action (NOA) 02/25/2004
  Inventory as of this Action Requested Previously Approved
05/31/2007 05/31/2007 05/31/2004
38,514 0 34,660
177,165 0 202,496
0 0 0

Sponsors of Investigational New Drug Applications are required, under the Food and Drug Administration Modernization Act, to submit information about clinical trials for serious or life-threatening diseases to a publicly-accessible clinical trials data bank developed by the National Library of Medicine.

None
None


No

1
IC Title Form No. Form Name
Information Program on Clinical Trials for Serious and Life-Threatening Diseases: Maintaining a Databank

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 38,514 34,660 0 0 3,854 0
Annual Time Burden (Hours) 177,165 202,496 0 0 -25,331 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/25/2004


© 2024 OMB.report | Privacy Policy